Premium Nahrungsergänzungsmittel | artgerecht

Hemostasis – Definition, Process and Disorders

Hemostasis is the natural process by which the body stops bleeding and seals wounds. It involves vascular response, platelets, and the coagulation cascade to prevent excessive blood loss.

Regular tips about health Regular tips about health

Things worth knowing about "Hemostasis"

Hemostasis is the natural process by which the body stops bleeding and seals wounds. It involves vascular response, platelets, and the coagulation cascade to prevent excessive blood loss.

What is Hemostasis?

Hemostasis is a vital physiological process that is triggered after a blood vessel is injured, stopping bleeding and initiating wound repair. It is a precisely regulated mechanism: it must act quickly enough to prevent blood loss, yet remain controlled to avoid the formation of dangerous blood clots (thrombosis). The term comes from the Greek words haima (blood) and stasis (standing still).

Phases of Hemostasis

1. Primary Hemostasis (Cellular Phase)

Immediately after a vessel injury, the affected blood vessel constricts (vasoconstriction) to slow blood flow. At the same time, platelets (thrombocytes) adhere to the damaged vessel wall and clump together, forming a loose platelet plug that temporarily seals the wound.

2. Secondary Hemostasis (Coagulation Cascade)

Secondary hemostasis involves the coagulation cascade – a series of biochemical reactions involving various clotting factors (proteins in the blood plasma). The end result of this cascade is the conversion of fibrinogen into fibrin. Fibrin forms a stable mesh that reinforces the platelet plug and creates a permanent blood clot (thrombus).

Intrinsic pathway: Activated by contact of blood with damaged tissue inside the vessel.
Extrinsic pathway: Triggered by tissue factor, which is released upon tissue injury outside the vessel.
Common pathway: Both pathways converge at the activation of Factor X, which drives the formation of thrombin and ultimately fibrin.

3. Fibrinolysis (Clot Dissolution)

Once the wound has healed, the clot is broken down through fibrinolysis. The enzyme plasmin degrades the fibrin network, allowing the blood vessel to regain full patency. This ensures that blood flow is restored after the healing process is complete.

Key Components Involved

Platelets (Thrombocytes): Small blood cells that are the first to respond to vessel injury.
Clotting Factors: Proteins (e.g., Factor VIII, Factor IX, Prothrombin) that orchestrate the coagulation cascade.
Von Willebrand Factor: An important protein that anchors platelets to the vessel wall.
Fibrin: The insoluble structural protein that stabilizes the clot.
Calcium (Ca²⁺): An essential cofactor throughout the coagulation cascade.

Disorders of Hemostasis

Hemostatic dysfunction can manifest in two directions:

Bleeding disorders (Hemorrhagic diathesis): Insufficient clotting leads to prolonged or excessive bleeding. Examples include Hemophilia A and B (deficiency of Factor VIII or IX respectively), Von Willebrand disease, or a low platelet count (thrombocytopenia).
Clotting disorders (Hypercoagulability): Overactive clotting leads to unwanted blood clots in blood vessels. Examples include Factor V Leiden mutation, antiphospholipid syndrome, or deficiencies in natural anticoagulant proteins such as Protein C or Protein S.

Diagnosis

Several laboratory tests are used to assess blood coagulation:

Prothrombin Time (PT) / INR: Measures the function of the extrinsic coagulation pathway; important for monitoring anticoagulant therapy.
aPTT (Activated Partial Thromboplastin Time): Evaluates the intrinsic coagulation pathway.
Platelet Count: Indicates the number of circulating platelets.
D-Dimers: Fibrin degradation products; elevated levels suggest active clotting or thrombosis.
Bleeding Time: Assesses primary hemostasis in clinical settings.

Medical Interventions for Clotting Disorders

Depending on the type of disorder, various treatment options are available:

Anticoagulants (Blood thinners): Medications such as heparin, warfarin, or direct oral anticoagulants (DOACs) inhibit clotting and are used when there is a risk of thrombosis.
Clotting Factor Concentrates: In hemophilia, missing clotting factors are replaced through infusion.
Platelet Transfusions: In severe thrombocytopenia, donor platelets may be administered.
Antifibrinolytics: Agents such as tranexamic acid inhibit fibrinolysis and are used to manage severe bleeding.

References

Hoffman R. et al.: Hematology: Basic Principles and Practice, 7th Edition, Elsevier, 2018.
Levi M., van der Poll T.: Coagulation and sepsis. Thrombosis Research, 2017; 149:38-44. Available via PubMed.
World Health Organization (WHO): Guidelines on the Management of Blood and Blood Products, WHO Press, Geneva, 2021.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.